However, to the best of our knowledge, this investigation is the first to evaluate the relationship between iron metabolism and infection risk in patients with RA on anti-IL-6R biologic therapy, and it has consistently demonstrated that a trend in iron metabolism for a higher extracellular iron availability predicts infection occurrence. Here, IL6R is linked to infection.